Fosun drops plan to sell stake in Gland Pharma: ReportShares of Gland Pharma were up 0.8% at 1,360 rupees as of 9:50 a.m. IST. They have plunged 28% since November end, when Bloomberg News had ...
26 Apr, 2023, 10.51 AM IST
Fosun taps big buyout funds for Gland PharmaBuyout firms Advent International, Baring Private Equity Asia (now owned by EQT), Bain Capital, Blackstone, Carlyle and KKR are among those...
14 Dec, 2022, 01.02 PM IST
Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...
29 Nov, 2022, 05.22 PM IST
Fosun Said to Mull Sale of India’s $3.6 Billion Gland PharmaA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
29 Nov, 2022, 04.53 PM IST
Gland Pharma rallies 9% as Fosun mulls selling controlling stake in firmA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
29 Nov, 2022, 03.24 PM IST
Chinese-owned Gland Pharma re-appoints Srinivas Sadu as MD & CEOGland Pharma reported revenues of Rs 3463 and a net profit of Rs 997 crore in FY21. Shares of Gland Pharma rose 1.89% to close at Rs 3360 o...
10 Mar, 2022, 06.30 PM IST
China's Fosun plans plant to make BioNTech's COVID-19 vaccine: CaixinThe first phase of the China-based manufacturing facility will have production capacity of 200 million doses, Caixin said, citing people fa...
31 Dec, 2020, 04.06 PM IST
74% Chinese-owned Hyderabad pharma firm files for IPOThe fresh issue and the offer for sale together is expected to take the IPO size to around Rs 3,000 crore.
12 Jul, 2020, 10.23 AM IST
Chinese firm-backed Gland Pharma files for IPO; may raise up to Rs 6,000 croreThe company may raise up to $800 million or Rs 6,000 crore, a source with the knowledge of the matter said.
10 Jul, 2020, 10.19 PM IST
China’s Fosun eyes stake in Ahuja ConstructionsThe Fosun Group is amongst China’s largest privately-owned investment conglomerates with interests spanning across pharmaceuticals, real es...
08 Mar, 2018, 08.08 AM IST
Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 billionFosun Pharma and Fosun International indirectly hold approximately 74 per cent equity interest in Gland Pharma, the joint statement added.
04 Oct, 2017, 06.58 PM IST
Fosun Group injects new life into Gland Pharma dealLast year, the government relaxed the foreign investment rules, allowing global companies to acquire up to 74 per cent in local drug makers...
23 Sep, 2017, 03.56 PM IST
FIPB refers Gland Pharma proposal to CCEA for approvalGland Pharma Limited is seeking approval for its initial acquisition of up to 86.08 per cent by Shanghai Fosun Pharmaceutical (Group) Compa...
24 Apr, 2017, 08.59 PM IST
Fosun agrees to buy KKR-backed Gland Pharma for $1.4 billion: SourceThe deal would be the first major move by the Fosun group since Guo Guangchang, founder of flagship holding firm Fosun International Ltd an...
29 Jul, 2016, 06.09 AM IST
China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billionShanghai Fosun will acquire the shares held by Gland Pharma founders Ravi Penmetsa and his family and PE giant KKR.
28 Jul, 2016, 12.49 AM IST
China's Fosun to buy KKR backed Gland Pharma for $1.4 billionFosun has agreed to acquire 96 percent stake, which includes shares held by founders of Gland Pharma Ravi Penmetsa and family and private e...
27 Jul, 2016, 10.37 AM IST
Fosun leads the race to buy Gland Pharma with $1.27 billion bidComing from behind in a closely fought race that saw US giant Baxter and private equity fund Advent make firm offers early May, Hong Kong-l...
06 Jun, 2016, 01.25 AM IST